Osteoarticular infection caused by MDRPseudomonas aeruginosa: the benefits of combination therapy with colistin plus β-lactams

The changing epidemiology of bacteraemic osteoarticular infections in the early 21st century

(2015) O. Murillo et al.   CLINICAL MICROBIOLOGY AND INFECTION

Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study

(2014) D. Rodríguez-Pardo et al.   CLINICAL MICROBIOLOGY AND INFECTION

Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model

(2014) J. Lora-Tamayo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality

(2013) C. Peña et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Bactericidal effect of colistin on planktonic Pseudomonas aeruginosa is independent of hydroxyl radical formation

(2013) Rikke Prejh Brochmann et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The MerR-Like Regulator BrlR Impairs Pseudomonas aeruginosa Biofilm Tolerance to Colistin by Repressing PhoPQ

(2013) J. R. Chambers et al.   JOURNAL OF BACTERIOLOGY

In VivoPharmacokinetics/Pharmacodynamics of Colistin and Imipenem in Pseudomonas aeruginosa Biofilm Infection

(2012) Wang Hengzhuang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America

(2012) D. R. Osmon et al.   CLINICAL INFECTIOUS DISEASES

Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial

(2012) J. M. Dulhunty et al.   CLINICAL INFECTIOUS DISEASES

The metabolically active subpopulation inPseudomonas aeruginosabiofilms survives exposure to membrane-targeting antimicrobials via distinct molecular mechanisms

(2012) Wen-Chi Chiang et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Difficult-to-treat Gram-negative bone and joint infections: efficacy and safety of prolonged intravenous colistin

(2012) Florent Valour et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?

(2012) Bruno Van Herendael et al.   Annals of Intensive Care

Synergistic Killing of Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula by Colistin Combined with Doripenem in an In Vitro Pharmacokinetic/Pharmacodynamic Model

(2011) Phillip J. Bergen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients

(2011) S. M. Garonzik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition

(2011) Cristina Suarez et al.   BMC INFECTIOUS DISEASES

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Prosthetic joint infection: diagnosis and management

(2011) Javier Cobo et al.   Expert Review of Anti-Infective Therapy

High-Dose Continuous Infusion β-Lactam Antibiotics for the Treatment of Resistant Pseudomonas Aeruginosa Infections in Immunocompromised Patients

(2010) Brad Moriyama et al.   ANNALS OF PHARMACOTHERAPY

Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model

(2010) P. J. Bergen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibiotic resistance of bacterial biofilms

(2010) Niels Høiby et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Colistin‐Tobramycin Combinations Are Superior to Monotherapy Concerning the Killing of BiofilmPseudomonas aeruginosa

(2010) Gloria Herrmann et al.   JOURNAL OF INFECTIOUS DISEASES

Continuous-Infusion β-Lactam Antibiotics During Continuous Venovenous Hemofiltration for the Treatment of Resistant Gram-Negative Bacteria

(2009) Brad Moriyama et al.   ANNALS OF PHARMACOTHERAPY

Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria

(2009) D. Plachouras et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Gram‐Negative Prosthetic Joint Infections: Risk Factors and Outcome of Treatment

(2009) Pang‐Hsin Hsieh et al.   CLINICAL INFECTIOUS DISEASES

Colistin in the 21st century

(2009) Roger L Nation et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Infection Associated with Prosthetic Joints

(2009) Jose L. Del Pozo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes

(2008) Sünje Johanna Pamp et al.   MOLECULAR MICROBIOLOGY

Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis

(2008) Andrej Trampuz et al.   Current Infectious Disease Reports